All Comments by Gerard Roberts
- Dale Schenk, 59, Pioneer of Alzheimer’s Immunotherapy
- Resolving Controversies on the Path to AD Therapeutics
- Chew the Fat—Lipids, NMDARs Mediate Neuronal Response to Aβ
- Washington: More Highlights from Drug Discovery Meeting, Part 2
- Amyloid Imaging: Laying PIB Concerns to Rest
- Breakthrough or False Hope? Etanercept Case Report Draws Scrutiny
- Tuebingen: Researchers Reminisce, Predict at Alzheimer Centennial
- Tuebingen: Researchers Reminisce, Predict at Alzheimer Centennial